Mark Hyman Rapaport, M.D. | Psychiatrist.com

Relationship Between MDD and Medical Conditions

Commentary

Relationship Between MDD and Medical Conditions

October 19, 2022

This commentary by Rachel A. Weir, MD, and Mark Hyman Rapaport, MD, discusses the article by Alix M. Arnaud, MSc, and colleagues on the overlap between major depressive disorder...

Rachel A. Weir, Mark Hyman Rapaport

Omega-3 Fatty Acids for MDD With High Inflammation

Original Research

Omega-3 Fatty Acids for MDD With High Inflammation

August 22, 2022

This study investigated whether dosage or inflammation levels affect response to omega-3s in MDD patients.

David Mischoulon, Boadie W. Dunlop, Becky Kinkead, et al

Commentary

Duration of a Major Depressive Episode

August 24, 2016

Read commentary about the duration of a major depressive episode and the New Empirical definition of recovery.

Boadie W. Dunlop, Mark Hyman Rapaport

Original Research

Massage Monotherapy Remediates Symptoms of Anxiety

July 27, 2016

Almost half of all people with generalized anxiety disorder seek some type of complementary and alternative therapy. See how massage therapy affected anxiety symptoms in this randomized controlled monotherapy...

Mark Hyman Rapaport, Pamela Schettler, Erika R. Larson, et al

Commentary

Patients' Preference for Complementary and Alternative Medicine Presents Challenges for Research

July 22, 2015

Mark Hyman Rapaport

Commentary

Antidepressant Signal Detection in the Clinical Trials Vortex

May 27, 2015

Boadie W. Dunlop, Mark Hyman Rapaport

Original Research

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

September 16, 2014

David Mischoulon, Andrew A. Nierenberg, Pamela J. Schettler, et al

Educational Activity

Beyond Acute Treatment of Depressive Disorders

July 21, 2009

Mark Hyman Rapaport

Educational Activity

Helping Patients With Depression Achieve Wellness

May 13, 2009

Mark Hyman Rapaport

ASCP Corner

Qualifications for Recertification: An Important but Evolving Set of Standards

November 30, 2008

Mark Hyman Rapaport, Deborah J. Hales

Original Research

Low Doses of Controlled-Release Paroxetine in the Treatment of Late-Life Depression: A Randomized, Placebo-Controlled Trial

October 7, 2008

Mark Hyman Rapaport, R. Bruce Lydiard, Cornelius D. Pitts, et al

Article

Dietary Restrictions and Drug Interactions With Monoamine Oxidase Inhibitors: The State of the Art

July 16, 2007

Mark Hyman Rapaport

1 2 »